15. Concerning β-adrenergic agonists as used in the treatment of asthma, which of the following statements are TRUE? ( a ). The mechanism of action is through activation of adenyl-cyclase, increasing intracellular c-AMP. (b) Oral delivery of β-adrenergic agonists has a similar side effect profile to that of aerosol delivery. (c). Tachycardia due to selective β-2 agonists may be due to “crossover” with β-1 stimulation as well as a reflex response to peripheral vasodilatation. (d). Breath activated powder inhalers require more patient coordination than metered dose inhalers.
(A) (a) + (b)
(B) (a) + (c)
(C) (a) + (b) + (d)
(D) (b) + (c) + (d)
詳解 (共 1 筆)
未解鎖
(a). 機制是透過活化酸酯酶增加細胞內...
私人筆記 (共 1 筆)
未解鎖
本題目討論的是β-肾上腺素能激动剂在治療...